Distinct domains of the μ-opioid receptor control uncoupling and internalization

被引:83
作者
Celver, J [1 ]
Xu, M [1 ]
Jin, WZ [1 ]
Lowe, J [1 ]
Chavkin, C [1 ]
机构
[1] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.1124/mol.65.3.528
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Homologous desensitization of the mu opioid receptor (muOR) can be resolved into distinct processes that include the uncoupling of the muOR from its G-protein effectors and internalization of cell surface receptors. Using electrophysiological recordings of muOR activation of G-protein-coupled K+ channels (K(ir)3) in Xenopus laevis oocytes and AtT20 cells, confocal microscopy of receptor localization, and radioligand binding of cell surface receptors, we resolved these desensitization mechanisms to determine the domain of muOR important for receptor uncoupling. Activation of muOR by saturating concentrations of [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO), methadone, or fentanyl, but not morphine, produced robust internalization of a green fluorescent protein-tagged muOR. A subsaturating concentration of DAMGO (100 nM) did not cause receptor internalization but markedly reduced the subsequent responsiveness of K(ir)3 by uncoupling muOR. muOR desensitization in AtT20 cells was confirmed to be homologous, because desensitization by 100 nM DAMGO was blocked by dominant-negative forms of either G protein-coupled receptor kinase (GRK) or arrestin, and pretreatment with DAMGO did not affect the K(ir)3 response to somatostatin receptor activation. Alanine substitution of a single threonine in the second cytoplasmic loop of the muOR ( Threonine 180) blocked agonist-dependent receptor uncoupling without affecting receptor internalization. These results suggest that GRK-dependent phosphorylation of muOR required threonine 180 for uncoupling but that a different GRK and arrestin-dependent mechanism controlled muOR internalization in AtT20 cells.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 44 条
  • [1] ADAMS JU, 1990, J PHARMACOL EXP THER, V255, P1027
  • [2] Alvarez VA, 2002, J NEUROSCI, V22, P5769
  • [3] Differential opioid agonist regulation of the mouse mu opioid receptor
    Blake, AD
    Bot, G
    Freeman, JC
    Reisine, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 782 - 790
  • [4] μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
    Bohn, LM
    Gainetdinov, RR
    Lin, FT
    Lefkowitz, RJ
    Caron, MG
    [J]. NATURE, 2000, 408 (6813) : 720 - 723
  • [5] Bohn LM, 2002, J NEUROSCI, V22, P10494
  • [6] Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors
    Borgland, SL
    Connor, M
    Osborne, PB
    Furness, JB
    Christie, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) : 18776 - 18784
  • [7] Molecular components of tolerance to opiates in single hippocampal neurons
    Bushell, T
    Endoh, T
    Simen, AA
    Ren, D
    Bindokas, VP
    Miller, RJ
    [J]. MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 55 - 64
  • [8] Threonine 180 is required for G-protein-coupled receptor kinase 3- and β-arrestin 2-mediated desensitization of the μ-opioid receptor in Xenopus oocytes
    Celver, JP
    Lowe, J
    Kovoor, A
    Gurevich, VV
    Chavkin, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) : 4894 - 4900
  • [9] OPIOID RECEPTOR RESERVE IN NORMAL AND MORPHINE-TOLERANT GUINEA-PIG ILEUM MYENTERIC PLEXUS
    CHAVKIN, C
    GOLDSTEIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22): : 7253 - 7257
  • [10] Regulation of opioid receptor function by chronic agonist exposure: Constitutive activity and desensitization
    Chavkin, C
    McLaughlin, JP
    Celver, JP
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (01) : 20 - 25